Charlotte Kluit is a senior commercial executive with 25+ years of experience in leading teams and talents for biopharmaceutical companies. Proven leader with track record of leading cross functional teams in the rapidly changing field of immuno-oncology and cell therapy. Pioneer in establishing successful teams, launching new therapies and enabling patient access. Charlotte currently works for Gilead Sciences with commercial responsibility for anti-fungal infections and Cell Therapy produced by Kite.